Potent Maturation of Monocyte-Derived Dendritic Cells After CD40L Lentiviral Gene Delivery
- 1 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 26 (5) , 451-460
- https://doi.org/10.1097/00002371-200309000-00008
Abstract
Dendritic cells (DCs) are being evaluated in immunization protocols to enhance immunity against infectious diseases and cancer. Interaction of T-helper cells expressing CD40 ligand (CD40L) with its cognate CD40 receptor on DCs leads to a mature DC phenotype, characterized by increased capacity of antigen presentation to cytotoxic T cells. The authors examined the ability of third-generation self-inactivating lentiviral vectors expressing CD40L to induce autonomous maturation of ex vivo expanded human monocyte-derived dendritic cells. Transduction with lentiviral vectors achieved a highly efficient gene transfer of CD40L to DCs, which correlated with phenotypic maturation as shown by the expression of immunologic relevant markers (CD83, CD80, MHCI) and secretion of IL-12, whereas DC phenotype was not affected by a control vector expressing only the green fluorescent protein marker. Addition of recombinant IFN-γ to DCs at the time of CD40L transduction further enhanced IL-12 production, and when co-cultured with allogeneic and autologous CD8+ and CD4+ T cells, a potent activation was observed. Autologous responses against an HLA-A2-restricted influenza peptide (Flu-M1) and a tumor-associated antigenic peptide (gp100 210M) were significantly enhanced when CD40L transduced DCs were used as antigen-presenting cells for in vitro stimulation of CD8+ cytotoxic T lymphocytes. These results demonstrate that endogenous expression of CD40L by lentivirally transduced DCs induced their autonomous maturation to a phenotype comparable to that induced by optimal concentrations of soluble CD40L, providing a novel tool for genetic manipulation of DCs.Keywords
This publication has 38 references indexed in Scilit:
- Effect of Adenovirus Gene Transfer Vectors on the Immunologic Functions of Mouse Dendritic CellsMolecular Therapy, 2002
- Cross-Strain Protection against Clinical and Laboratory Strains ofPseudomonas aeruginosaMediated by Dendritic Cells Genetically Modified to Express CD40 Ligand and Pulsed with Specific Strains ofPseudomonas aeruginosaHuman Gene Therapy, 2001
- Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4+ Vα24 natural killer T cells expressing CD40LImmunology, 2001
- Review: Gene-Modified Dendritic Cells for Use in Tumor VaccinesHuman Gene Therapy, 2000
- Transduction of Human PBMC-Derived Dendritic Cells and Macrophages by an HIV-1-Based Lentiviral Vector SystemMolecular Therapy, 2000
- Dendritic Cell Secretion of IL-15 Is Induced by Recombinant huCD40LT and Augments the Stimulation of Antigen-Specific Cytolytic T CellsCellular Immunology, 1999
- CD40 ligand inhibits Fas/CD95‐mediated apoptosis of human blood‐derived dendritic cellsEuropean Journal of Immunology, 1997
- Proliferating dendritic cell progenitors in human blood.The Journal of Experimental Medicine, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- The CD40 Antigen and its LigandAnnual Review of Immunology, 1994